XML 26 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating expenses:      
Research and development, net $ 16,954 $ 14,083 $ 12,550
Marketing and business development expenses 1,614 887 549
General and administrative 7,704 3,590 5,265
Operating loss 26,272 18,560 18,364
Financial (income) expense, net 10,597 (11,655) (24,281)
Net (profit) loss 36,869 6,905 (5,917)
Deemed dividend 2,114
Net loss attributable to Ordinary shares $ 38,983 $ 6,905 $ (5,917)
Basic net (profit) loss per Ordinary share (in Dollars per share) $ 4.48 $ 23.69 $ (0.16)
Diluted net loss per Ordinary share (in Dollars per share) $ 4.48 $ 23.69 $ 0.86
Weighted average number of Ordinary shares used in computing basic net (profit) loss per share (in Shares) 9,582,405 562,451 561,113
Weighted average number of Ordinary shares used in computing diluted net loss per share (in Shares) 9,582,405 562,451 613,358